This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as a Hybrid Event, March, 2022
Live In-Person: March 14-15 in Miami, FLDigital Experience: March 16-17

Julie G. Holtzople
Head of Clinical Transparency and Data Sharing at AstraZeneca


Julie Holtzople is the Head of Clinical Transparency and Data Sharing for AstraZeneca. Prior to joining AstraZeneca, Julie worked as a management consultant for Ernst & Young and Booz Allen Hamilton. As a consultant Julie focused in the Health Care industry to deliver systems, process improvement initiatives, change management, and program management. As Head of Clinical Transparency and Data Sharing, Julie is accountable for AstraZeneca’s Trial Results Summary program, delivery of anonymized clinical documents for Health Canada’s PRCI process and similar regulations, and AstraZeneca’s process for external data sharing with researchers. As part of her role, Julie is actively involved in several industry organizations that are focused on implementing best practices within the Clinical Trial Transparency space, including Transcelerate, Pharma, Efpia and Phuse.

Agenda Sessions

  • CASE STUDY: Optimising Internal Processes to Meet All Disclosure Requirements

  • PANEL: Balancing Timely Disclosure, Meeting Regulations whilst Maintaining Trial Integrity